Profil
Glenn Fu is the founder of Cellular Research, Inc. which was founded in 2011.
He held the title of Senior Scientist from 2011 to 2016.
Dr. Fu has an undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of Michigan.
Ehemalige bekannte Positionen von Glenn Fu
| Unternehmen | Position | Ende |
|---|---|---|
Cellular Research, Inc.
 Cellular Research, Inc. BiotechnologyHealth Technology Cellular Research, Inc. operates as a biotechnology research and development company. It offer Precise assays that provides quantitation of mRNA targets in single cells and small samples; precise predefined gene expression panels; and Pixel system, a detection platform for direct mRNA quantitation from single cells and rare samples. The company’s products are used in various applications that include gene expression validation, RNA-seq validation, pathway validation, and rare transcript detection. The company was founded by Stephen P. A. Fodor, Ari Chaney, Stephen R. Quake and Glenn Fu in 2011 and is headquartered in Menlo Park, CA. | Gründer | 01.07.2016 |
Ausbildung von Glenn Fu
| University of California, Berkeley | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cellular Research, Inc.
Cellular Research, Inc. BiotechnologyHealth Technology Cellular Research, Inc. operates as a biotechnology research and development company. It offer Precise assays that provides quantitation of mRNA targets in single cells and small samples; precise predefined gene expression panels; and Pixel system, a detection platform for direct mRNA quantitation from single cells and rare samples. The company’s products are used in various applications that include gene expression validation, RNA-seq validation, pathway validation, and rare transcript detection. The company was founded by Stephen P. A. Fodor, Ari Chaney, Stephen R. Quake and Glenn Fu in 2011 and is headquartered in Menlo Park, CA. | Health Technology |
